18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.
about
18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
18F-Fluoroestradiol PET/CT Mea ...... g Dosage in Subsequent Trials.
@en
type
label
18F-Fluoroestradiol PET/CT Mea ...... g Dosage in Subsequent Trials.
@en
prefLabel
18F-Fluoroestradiol PET/CT Mea ...... g Dosage in Subsequent Trials.
@en
P2093
P2860
P1476
18F-Fluoroestradiol PET/CT Mea ...... g Dosage in Subsequent Trials.
@en
P2093
Aditya Bardia
Carlos L Arteaga
Debra A Goldman
Eric Winer
Gary A Ulaner
Henry C Manning
Ingrid A Mayer
Jill Fredrickson
José Baselga
Karen L Ayres
P2860
P304
P356
10.1158/1078-0432.CCR-16-2197
P407
P577
2016-12-23T00:00:00Z